Researchers evaluated data from 13 different studies, sharing their findings in Annals of Palliative Medicine.

ICD use among this patient population is slowly growing, but some key disparities remain.

Old age, a history of arrhythmia and obesity are just some of the factors clinicians should keep in mind when treating HCM patients. 

Researchers evaluated 11 different prediction models, and each one fell short.

The study included more than 2,000 older adults who were followed for up to 12 years.

Outcomes from patients prescribed apixaban, rivaroxaban or dabigatran were compared with outcomes from patients given warfarin. 

The new analysis showed why women struggling to fully recover from COVID-19 may benefit from a targeted rehab program.